deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Bre...(Ps) in the human genome that deCODE and ...),Health

Date:10/8/2008

Ps) in the human genome that deCODE and others have linked to risk of breast cancer. These SNPs contribute to the incidence of an estimated 60 percent of all breast cancers. The test integrates data from discovery and replication studies published in major peer-reviewed journals and involving nearly 100,000 breast cancer patients and healthy volunteers from many populations, principally of European descent. deCODE and other organizations are conducting replication studies to validate these markers in populations of other continental ancestries.

Women taking the deCODE BreastCancer(TM) test will receive a numerical score representing their relative risk of developing breast cancer in their lifetime compared to that of the general population as well as their personal lifetime risk. According to the American Cancer Society, average lifetime risk for women of European descent is 12 percent. Test scores range from 4.0 times average lifetime risk to less than half, or 0.4-times. The risk assessed by deCODE BreastCancer(TM) is independent of conventional risk factors such as family history of breast cancer in close relatives, age at first menstrual period, pregnancy history, and breast density. Therefore, this genetic risk should be viewed in the context of other risk factors assessed by a woman's physician.

deCODE BreastCancer(TM) can identify the roughly 5 percent of women who are at a greater than 20 percent lifetime risk of the common forms of breast cancer (about twice the average risk in the general population), and the 1 percent of women whose lifetime risk is roughly 36 percent (about three-times average). According to ACS guidelines, women with a lifetime risk of 20 percent or greater should receive annual MRI breast screenings in addition to mammograms, and women at 15 to 20 percent lifetime risk should talk with their doctors about the benefits and limitations of adding MRI screening to their yearly mammogram. With the information provided by the d
'/>"/>

SOURCE deCODE Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related medicine news :

1. Open Biosystems Launches Decode RNAi Viral Screening Pools for Low-Cost Genome-Scale RNAi Screens
2. deCODE genetics to Webcast Presentation at Piper Jaffray Annual Healthcare Conference
3. deCODE genetics to Webcast Presentation at Lazard Capital Markets Annual Healthcare Conference
4. Candice Lane MD Launches Hormone Health MD Plus: The First Doctor Bioidentical Hormone Blog
5. Quantros Launches Patient Safety Organization Manager to Streamline PSO Data Management and Submission to the Network of Patient Safety Databases
6. Albertsons LLC Launches $4.99 Prescription Discount Program Covering Over 500 Generic Drugs
7. Reflex Stock Launches Exciting New Editorial Image Collections to the Worldwide Publishing Industry
8. Bounty Launches New Survival Guide Website for Dads
9. PPTA Launches New Educational Website on Donating Plasma
10. Drumlin Security Launches Ground-breaking Low Cost PDF Publishing Service
11. USHEALTH Group Launches Marketing Program for Two Health Insurance Plans Targeting Latino Residents in Florida